
Vaxart Inc.
VXRT,
+96.23%
said Friday its oral COVID-19 vaccine has been selected to take part in a non-human primate challenge study funded by the U.S. government’s ‘Operation Warp Speed’ prog… [+716 chars]

Vaxart Inc.
VXRT,
+96.23%
said Friday its oral COVID-19 vaccine has been selected to take part in a non-human primate challenge study funded by the U.S. government’s ‘Operation Warp Speed’ prog… [+716 chars]